
Redentor M. Pasia
Examiner (ID: 16815, Phone: (571)272-9745 , Office: P/2479 )
| Most Active Art Unit | 2413 |
| Art Unit(s) | 2616, 2413, 2474, 2479, 2416 |
| Total Applications | 771 |
| Issued Applications | 563 |
| Pending Applications | 74 |
| Abandoned Applications | 158 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8950593
[patent_doc_number] => 20130196373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'MODIFIED DNA-BINDING PROTEINS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/679684
[patent_app_country] => US
[patent_app_date] => 2012-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 44861
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13679684
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/679684 | Modified DNA-binding proteins and uses thereof | Nov 15, 2012 | Issued |
Array
(
[id] => 11298077
[patent_doc_number] => 09506073
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-29
[patent_title] => 'Blue-light inducible system for gene expression'
[patent_app_type] => utility
[patent_app_number] => 14/359030
[patent_app_country] => US
[patent_app_date] => 2012-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 25
[patent_no_of_words] => 12710
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14359030
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/359030 | Blue-light inducible system for gene expression | Nov 15, 2012 | Issued |
Array
(
[id] => 9656722
[patent_doc_number] => 20140227727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'UNCONVENTIONAL PROTEIN SECRETION'
[patent_app_type] => utility
[patent_app_number] => 14/349999
[patent_app_country] => US
[patent_app_date] => 2012-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 26908
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14349999
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/349999 | UNCONVENTIONAL PROTEIN SECRETION | Oct 3, 2012 | Abandoned |
Array
(
[id] => 12347538
[patent_doc_number] => 09951349
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-24
[patent_title] => Compositions and methods for transient expression of recombinant RNA
[patent_app_type] => utility
[patent_app_number] => 14/343817
[patent_app_country] => US
[patent_app_date] => 2012-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 19
[patent_no_of_words] => 23393
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343817
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/343817 | Compositions and methods for transient expression of recombinant RNA | Sep 26, 2012 | Issued |
Array
(
[id] => 10275197
[patent_doc_number] => 20150160194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-11
[patent_title] => 'METHOD FOR SCREENING FOR SUBSTANCE'
[patent_app_type] => utility
[patent_app_number] => 14/343533
[patent_app_country] => US
[patent_app_date] => 2012-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10801
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343533
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/343533 | Method of screening for substances capable of promoting induction of induced pluripotent stem cells | Sep 11, 2012 | Issued |
Array
(
[id] => 10908891
[patent_doc_number] => 20140311907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'SYSTEMS AND METHODS FOR ASSAY OF BIO-CONTAMINANTS IN WATER'
[patent_app_type] => utility
[patent_app_number] => 14/343846
[patent_app_country] => US
[patent_app_date] => 2012-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 10742
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343846
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/343846 | Systems and methods for assessing contamination of drinking water | Sep 7, 2012 | Issued |
Array
(
[id] => 10975501
[patent_doc_number] => 20140378537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'TREATMENT OF TH17 MEDIATED INFLAMMATORY DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/343255
[patent_app_country] => US
[patent_app_date] => 2012-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 25199
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343255
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/343255 | TREATMENT OF TH17 MEDIATED INFLAMMATORY DISEASES | Sep 6, 2012 | Abandoned |
Array
(
[id] => 13105001
[patent_doc_number] => 10071129
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-11
[patent_title] => Method for identifying bromodomain inhibitors
[patent_app_type] => utility
[patent_app_number] => 14/342265
[patent_app_country] => US
[patent_app_date] => 2012-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16324
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 233
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14342265
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/342265 | Method for identifying bromodomain inhibitors | Aug 29, 2012 | Issued |
Array
(
[id] => 8697723
[patent_doc_number] => 20130059732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'AAV CAPSID PROTEINS FOR NUCLEIC ACID TRANSFER'
[patent_app_type] => utility
[patent_app_number] => 13/594773
[patent_app_country] => US
[patent_app_date] => 2012-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 16216
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13594773
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/594773 | AAV capsid proteins for nucleic acid transfer | Aug 23, 2012 | Issued |
Array
(
[id] => 8566480
[patent_doc_number] => 20120329051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-27
[patent_title] => 'METHODS OF EVALUATING CELLS AND CELL CULTURES'
[patent_app_type] => utility
[patent_app_number] => 13/584507
[patent_app_country] => US
[patent_app_date] => 2012-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12727
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13584507
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/584507 | METHODS OF EVALUATING CELLS AND CELL CULTURES | Aug 12, 2012 | Abandoned |
Array
(
[id] => 9616716
[patent_doc_number] => 20140206572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-24
[patent_title] => 'OVARIAN MARKERS OF FOLLICULAR MATURITY AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/234671
[patent_app_country] => US
[patent_app_date] => 2012-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 18452
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14234671
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/234671 | OVARIAN MARKERS OF FOLLICULAR MATURITY AND USES THEREOF | Jul 23, 2012 | Abandoned |
Array
(
[id] => 8637623
[patent_doc_number] => 20130029426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-31
[patent_title] => 'Dual Inducible System for the cSPP System'
[patent_app_type] => utility
[patent_app_number] => 13/556100
[patent_app_country] => US
[patent_app_date] => 2012-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9929
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13556100
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/556100 | Dual inducible system for the condensed single protein production system | Jul 22, 2012 | Issued |
Array
(
[id] => 8841545
[patent_doc_number] => 20130137173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-30
[patent_title] => 'NUCLEOTIDE-SPECIFIC RECOGNITION SEQUENCES FOR DESIGNER TAL EFFECTORS'
[patent_app_type] => utility
[patent_app_number] => 13/554922
[patent_app_country] => US
[patent_app_date] => 2012-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 45206
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13554922
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/554922 | NUCLEOTIDE-SPECIFIC RECOGNITION SEQUENCES FOR DESIGNER TAL EFFECTORS | Jul 19, 2012 | Abandoned |
Array
(
[id] => 9983435
[patent_doc_number] => 09029143
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-12
[patent_title] => 'MUTZ-3 dendritic cells'
[patent_app_type] => utility
[patent_app_number] => 13/553157
[patent_app_country] => US
[patent_app_date] => 2012-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12671
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13553157
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/553157 | MUTZ-3 dendritic cells | Jul 18, 2012 | Issued |
Array
(
[id] => 11264360
[patent_doc_number] => 09488654
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-08
[patent_title] => 'Methods for predicting response of triple-negative breast cancer to therapy'
[patent_app_type] => utility
[patent_app_number] => 13/545947
[patent_app_country] => US
[patent_app_date] => 2012-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 27918
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 337
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13545947
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/545947 | Methods for predicting response of triple-negative breast cancer to therapy | Jul 9, 2012 | Issued |
Array
(
[id] => 9671112
[patent_doc_number] => 20140234975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'METHOD FOR INCREASING THE EFFICIENCY OF DOUBLE-STRAND-BREAK INDUCED MUTAGENESIS'
[patent_app_type] => utility
[patent_app_number] => 14/131210
[patent_app_country] => US
[patent_app_date] => 2012-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17281
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14131210
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/131210 | Method for increasing the efficiency of double-strand-break induced mutagenesis | Jul 2, 2012 | Issued |
Array
(
[id] => 8566005
[patent_doc_number] => 20120328576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-27
[patent_title] => 'DEFINED DOSE THERAPEUTIC PHAGE'
[patent_app_type] => utility
[patent_app_number] => 13/537616
[patent_app_country] => US
[patent_app_date] => 2012-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22309
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13537616
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/537616 | DEFINED DOSE THERAPEUTIC PHAGE | Jun 28, 2012 | Abandoned |
Array
(
[id] => 14975533
[patent_doc_number] => 10441653
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-15
[patent_title] => Nucleic acid comprising G
[patent_app_type] => utility
[patent_app_number] => 13/492787
[patent_app_country] => US
[patent_app_date] => 2012-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 28028
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13492787
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/492787 | Nucleic acid comprising G | Jun 7, 2012 | Issued |
Array
(
[id] => 10814125
[patent_doc_number] => 20160160285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'METHOD FOR DETECTING GENES SENSITIVE TO LOW-LEVEL IONIZING RADIATION, AND GENE DETECTED BY THE METHOD'
[patent_app_type] => utility
[patent_app_number] => 14/399953
[patent_app_country] => US
[patent_app_date] => 2012-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3947
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14399953
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/399953 | Method for detecting genes sensitive to low-level ionizing radiation, and gene detected by the method | May 17, 2012 | Issued |
Array
(
[id] => 11305101
[patent_doc_number] => 09512489
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-06
[patent_title] => 'Method for detecting genes sensitive to low-level ionizing radiation'
[patent_app_type] => utility
[patent_app_number] => 14/399954
[patent_app_country] => US
[patent_app_date] => 2012-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3358
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14399954
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/399954 | Method for detecting genes sensitive to low-level ionizing radiation | May 17, 2012 | Issued |